NCT00545558View on ClinicalTrials.gov

Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Hepatitis CHIV Infections
Interventions
DRUG

Efavirenz

600 mg tablet taken orally daily

DRUG

Emtricitabine/Tenofovir disoproxil fumarate

200 mg emtricitabine/ 300 mg tenofovir disoproxil fumarate tablet taken orally daily

Trial Locations (2)

23298

Virginia Commonwealth University, School of Medicine, Richmond

45229

General Clinical Research Center (GCRC), OH site, Cincinnati

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of Cincinnati

OTHER

NCT00545558 - Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV | Biotech Hunter | Biotech Hunter